HC Wainwright & Co. Maintains Buy on OKYO Pharma, Raises Price Target to $7

Benzinga · 03/22 15:05
HC Wainwright & Co. analyst Yi Chen maintains OKYO Pharma (NASDAQ:OKYO) with a Buy and raises the price target from $6 to $7.